PRMT5 activity possesses myeloproliferative effects that stem from its interaction with receptor tyrosine kinase FLT3, a protein often mutated in acute myeloid leukemia (AML) [91]. The gene discussed is NTRK1; the disease is acute myeloid leukemia.